As an essential receptor of coronavirus infection, ACE2 has also been found to bind to S pro with high affinity in SARS-CoV-2, which is considered as a therapeutic target for COVID-19 patients (Sharma et al., 2022). The gene discussed is ACE2; the disease is COVID-19.